GLP-1 medications improve glucose control and reduce systemic inflammation, which may reduce glycation stress on collagen
The FDA has not reviewed or approved concurrent use of these agents, and compounding pharmacies operate within state regulations that require clinical oversight
Bodnaruc AM, Prud'homme D, Blanchet R, Giroux I
Nevertheless, as the simultaneous activation of GLP-1 and GIP receptors in preclinical models results in greater WL and glucose-lowering efficacy compared to activation of each receptor alone [38,39,40], the interest for the development of unimolecular GLP-1 and GIP RA was increased, despite that this additive effect in food intake and glycaemia was not observed in some acute clinical studies [41, 42]
This gas is produced naturally when bacteria in your digestive tract break down sulfur-containing compounds from food
Never stop or adjust diabetes medications without medical guidance, as this requires careful planning to maintain glycaemic control whilst ensuring surgical safety
